Catalyst Wire Dossier Catalyst Wire Dossier

GSK3128349

GSK3128349 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3128349, covering 2018-09-07 to 2018-09-07. Get the full timeline:

Most recent: Clinical Trial Update: A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects [Phase 1]

See pricing